Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Watch CBS News
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Jennifer Frederick didn't understand why she had a growing lump under her skin. A doctor returned a devastating diagnosis.
The CDC says White men are more likely to get melanoma, but the study found that Black men are 26% more likely to die from the disease.
